CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![agenic-ai-GettyImages-2195607659]( "The Intelligent Teammate: Agentic AI As A Catalyst For Clinical Innovation")
The Intelligent Teammate: Agentic AI As A Catalyst For Clinical InnovationAgentic AI cuts variability, speeds clinical workflows, and strengthens compliance. It boosts efficiency and supports teams as research demands grow. Explore the full article for insights.
-
![Medical health, cloud data-GettyImages-2191629602]( "We Made Five Predictions For Clinical Research Last Year. Here's What Happened")
We Made Five Predictions For Clinical Research Last Year. Here's What HappenedReview 2025’s gap between AI discovery and trial execution, highlighting legislative and FDA shifts to help sponsors operationalize participant experience for 2026.
-
![ai-pre-award-landscape-analysis-GettyImages-2092028381]( "Harnessing AI for Pre-Award Landscape Analysis And Site Selection")
Harnessing AI for Pre-Award Landscape Analysis And Site SelectionAI-driven insights transform site selection and feasibility, enabling faster decisions and reducing risk. Predictive modeling and real-time data improve pre-award planning and trial outcomes.
-
![year 2026-GettyImages-1453824292]( "Clinical Development Crystal Ball: What To Watch In 2026")
Clinical Development Crystal Ball: What To Watch In 2026Explore how AI integration, remote assessment, and precision measurement are reshaping clinical trials in 2026 to improve data quality and patient outcomes.
-
![computer engineers programming software-GettyImages-968289884]( "Why Risk-Based Thinking Is Transforming Life Sciences Validation")
Why Risk-Based Thinking Is Transforming Life Sciences ValidationThe FDA’s CSA framework replaces traditional CSV with a risk-based approach, reducing inefficiencies and enabling faster innovation. Learn why this shift matters for your organization.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Changing The Clinical Feasibility Game With AI1/22/2026
AI is only as good as the data it’s built upon. Our customized AI platforms are constructed on a foundation of trustworthy, carefully curated data to produce detailed, expert-driven responses.
-
Drilling Down On Diversity And Feasibility12/8/2025
A mid-sized contract research organization (CRO) sought help with writing clinical trial diversity action plans and assessing feasibility for therapeutic areas outside its usual scope.
-
Accelerating Clinical Data Review With Traceable Workflows12/3/2025
Clinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.
-
Rescuing Data Integrity: A Swift Transition And Quality Transformation11/14/2025
Uncover how this collaboration supported timely progress toward key study milestones, enabling smoother execution and more dependable output across data management and statistical activities.
-
Effect Of Etrasimod On Immune Cell Subsets In Colonic Tissue9/25/2025
Etrasimod selectively modulates S1P receptors to reduce inflammation and immune cell trafficking to the gut, showing promise in treating moderate to severe ulcerative colitis.
CENTRAL LABORATORIES PRODUCTS & SERVICES
Technology solutions for life sciences that get products to market quickly and efficiently.
The ISPOR Education Center provides instant access to Health Economics and Outcomes Research (HEOR) education with on-demand programs delivered through a personalized, powerful, and flexible learning platform. Working at their own time and pace, individuals can drive their professional development by growing their knowledge and skills with topical, relevant, and innovative course curricula.
The Revvity Signals Software Risk-Based Monitoring Solution is the most effective way to leverage data-driven insights to optimize site performance while improving patient safety.
Enables secure real-time document review, co-authoring, and redaction in order to shorten the document review process by up to 65%.
Computer System Validation to cover all your GMP, GLP, GCP, and QA/QC software applications. CompliancePath currently has 30+ active projects globally supporting clients in CSV/CSA compliance.
ProPharma has deep expertise across all signal detection and management activities, including validation, prioritization, and assessment using data from a wide range of sources that are relevant for signal detection for the individual product(s). We are also fully trained and experienced in the EudraVigilance Data Analysis System (EVDAS) functionality and can support MAHs to comply with their obligations for signal detection and management. We leverage our robust knowledge to select the most efficient and effective method(s) for each product that is compliant with legislative requirements.
CENTRAL LABORATORIES SOLUTIONS
- Intelligent Trials: Design and Execute Faster Trials with AI-Powered Insights
- Simulants: Unlock Insights And Accelerate Medical Breakthroughs
- Unlock Your Clinical Imaging Data Potential
- Drive Automation And Efficiency In Your Interim Lock Process
- Unifying Data Management For Clinical Trials
- What Our Portal Does For Sites, Sponsors, And Patients
- Advarra Cloud
- Powering Smarter Treatments And Healthier People
- How The Sitetrove Diversity Module Can Diversify Studies
- Rave TSDV - Improve CRA Efficiency And Reduce Site Burden
VIDEOS
- Revolutionize Data Access With An AI Powered Custom Listing Generator
- How AI-Enhanced CAPA Systems Cut Non-Conformances By Targeting Root Causes
- The Industry’s First And Only Unified Platform For RWE Generation
- AI Importer — See It in Action!
- Protect Personally Identifiable Information (PII) With My Medidata
NEWS
- Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America
- Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials
- Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience
- Yoncare s.r.o. Partners With Block Clinical Inc. To Deliver EU-Centric Clinical Trial Participant Travel And Payment Services In Europe
- Block Clinical Discusses Patient Travel Support With Panel Members
- Quotient Sciences And Intrepid Labs Form Strategic Partnership To Accelerate AI-Guided Formulation Development
- One App To Simplify The Clinical Trial Journey
- Avance Clinical Showcases Early Phase Expertise And The Australian Advantage For EU Biotechs At BIO-Europe Vienna
- Meet Avance Clinical At SCOPE Summit 2026 In Orlando, Florida
- Signant Health Appoints Internationally Recognized Cognitive Assessment Expert John Harrison To Further Advance Innovation In CNS Clinical Trials
- Avance Clinical Launches Renal And Cardiometabolic Center Of Excellence To Optimize Patient Recruitment To Elevate Study Success
- Avance Clinical Unveils Dedicated CNS Center Of Excellence For Expert Clinical Trial Services In Neuroscience
- Suvoda Expands EU Patient Travel with Bolt Partnership
- Avance Clinical Launches Dedicated Center Of Excellence To Accelerate Early Phase Biotech Trials
- Castor Catalyst: Launching Self-Driving Clinical Trials With Google Cloud AI
- Almac Trial Coordinator Launched In $48 Million Investment To Advance Integrated eClinical Technologies
- Quotient Sciences And Biorasi Partner To Accelerate Early Phase Clinical Trials To Patient Proof-Of-Concept
- Biorasi Unveils New Website To Drive Sponsor Success With Biotech-Centric Strategies And Modular CRO Solutions
- Suvoda And Greenphire Complete Brand Integration With Unified Website And Social Media Presence
- Avance Clinical Accelerates Time To Pivotal Milestones For More Than 700 Emerging Biotechs
- Avance Clinical Attends Reception Welcoming Australia's US Ambassador To North Carolina Governor's Executive Mansion In Raleigh, N.C.
- Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, And Regional Collaboration
- "Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns
- ISPOR Real-World Evidence Summit 28-30 September 2025, Tokyo, Japan
- Ametris Expands Collaborative Research Project To Investigate Digital Measures Of Physical Function For Drug Development in Obesity
- Quotient Sciences And CPI To Accelerate RNA Drug Development With Joint Venture
- Biorasi And Ryght AI Partner To Revolutionize Clinical Trial Feasibility With Real-Time AI Insights
- PCM Trials, EmVenio Research, And Clinical Trial Service Rebrand As EmVenio Clinical Research
- CORE 2025 - October 6-8, 2025
- Crucial Data Solutions Names Dr. Leigh J. Mack Chief Medical Officer Amid Industry AI Shift